Founder's key components: ESR1 (ERalpha), ESR2 (ERbeta), coactivators.
DRY status: none located. Queries as listed in the DRY column above. No ER or estradiol measurement under any no-water protocol was located.
The structural finding first
No human fasting study measuring ESR1, ESR2 or coactivator expression, occupancy or transcriptional output was located. Three syntheses were opened and searched for receptor-level data: La Vignera and Condorelli 2026 (Nutrients 18(11):1817), Poursalehian et al. 2024 (PLoS ONE 19(5):e0299695), and the mechanism sections and reference list of the first. All three report circulating hormone concentrations only. The 2026 review's own mechanistic content is ligand-side and hypothalamic (GnRH, kisspeptin, NPY, leptin, SHBG). The honest reading: fasting changes the ligand supply to this receptor in some populations. Whether the receptor itself changes is unmeasured in humans.
Disconfirming, nulls and failed replications
[ROW H3 / RAMADAN / B] Poursalehian et al. 2024, PLoS ONE 19(5):e0299695, DOI 10.1371/journal.pone.0299695. 35 studies, 1,107 participants (783 men, 271 women, 53 sex unknown), published 1982 to 2021, mean fast 13.44 +/- 1.97 h/day across 28 studies. Testosterone, LH, FSH and prolactin pooled null. Estradiol was not pooled at all. Internal defects READ from the article: the abstract labels null results "P-value<0.05"; the Discussion says free T4 fell significantly while the Results report no significant change; cortisol is "substantial" in the abstract and "large insignificant" in the Results (Hedges' g = -2.14, 95% CI -4.54 to 0.27, p = 0.08). A meta-analysis that contradicts its own results text is not a clean null and is reported here as a contested null, not as evidence for either direction.
[ROW H3 / RAMADAN / C] Caglayan et al. 2014, Clin Exp Obstet Gynecol 41:17-19, DOI 10.12891/ceog15722014. 30 healthy women. LH, FSH, estradiol, testosterone and prolactin all non-significant. Reference string READ from La Vignera 2026 reference list, article not opened.
[ROW H1 / TRE / C] Cienfuegos et al. 2024, medRxiv, DOI 10.1101/2024.05.15.24307415. 12-month RCT of 8 h TRE in adults with obesity. In postmenopausal women estradiol, estrone and progesterone unchanged. This is the longest TRE trial located and it is null for estrogens. Preprint, not peer-reviewed, so it carries reduced weight in both directions.
[ROW H2 / TRE / C] Kalam et al. 2022, Obesity 30:2117-2119, DOI 10.1002/oby.23562. In postmenopausal females estrogens, progesterone and contraceptive hormones unchanged; DHEA decreased. In premenopausal females androgens and SHBG unchanged; DHEA decreased.
Supporting evidence
[ROW H3 / TRE / C] Güven 2023, Nutrients 15:2260, DOI 10.3390/nu15102260. 6 weeks of 8 h TRF in 30 women with PCOS. Estradiol decreased, with AMH, FSH, LH, prolactin, total and free testosterone also decreased, free androgen index down, SHBG up. Single arm in a disease population. The citing review calls it an "intervention study" in text and an RCT in its quality table, and rates the PCOS evidence STRONG in one section and MODERATE in its own assessment. Design and strength are internally contradictory in the only positive human estradiol row located.
[ROW H3 / TRE+CR / C] Cienfuegos et al. 2022, Nutrients 14:2343, DOI 10.3390/nu14112343 (review of human trials). In premenopausal women with obesity, earlier-eating IF lowered testosterone and free androgen index and raised SHBG; estrogen, LH, FSH and prolactin not affected.
[ROW A1 / IF-ADF / C] Kumar and Kaur 2013, PLoS ONE 8:e52416, DOI 10.1371/journal.pone.0052416. Young female rats, every-other-day food deprivation: kisspeptin and GnRH expression in the median eminence decreased, LH and sex steroids reduced, serum leptin decreased. Reference string and findings READ from La Vignera 2026, article not opened. Note the direction conflict against the same review's report that estradiol rose in IF-DR female rats. Reported unresolved.
Conflict left open
Ramadan meta-analysis null versus PCOS single-arm decrease versus 12-month TRE RCT null. The modalities differ (dawn-to-dusk with fluid restriction, 8 h window, 8 h window) and the populations differ (healthy, PCOS, obesity). No winner is picked here.
Node 11 verdict
- Receptor-level grade: C. No human or animal measurement of ESR1/ESR2/coactivators under fasting located. Best tier for the receptor itself: M.
- Ligand-axis grade: B. Human biomarker data exist and conflict. Best tier H1, and the H1 row is null.
- This node must not be written as "fasting modulates estrogen receptor signaling." What is supportable is that some fasting modalities change circulating estrogen and gonadotropin levels in some populations, with meta-analytic nulls in RAMADAN and a null in the longest TRE trial.
Open questions
1. Has ESR1 or ESR2 expression been measured in any human tissue under any fasting modality? Not located. 2. Does the Güven PCOS decrease replicate in a randomized design with a non-PCOS arm? Not located. 3. Is estradiol poolable across Ramadan studies, and why did the 35-study meta-analysis omit it?
← 10. HIF / hypoxia All 41 nodes 12. Androgen receptor (AR) →
dryfasting.com has been published since 2014. This evidence record was compiled on 22 November 2026. Every row names the fasting modality the study actually ran, the system it was measured in and the grade. Where no source carries a DOI or PMID the row says so rather than supplying one. Nothing is sold on this site.